Health Care & Life Sciences » Pharmaceuticals | Vectura Group PLC

Vectura Group PLC

Vectura Group PLC
Stock Exchange Other OTC
EPS
 $0.17
Market Cap
 $699.62 M
Shares Outstanding
 665.22 M
Public Float
 -
Vectura Group PLC
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 665.3 M
Public Float
 -
Vectura Group PLC
Stock Exchange London Stock Exchange
EPS
 GBP0.13
Market Cap
 GBP553.03 M
Shares Outstanding
 665.3 M
Public Float
 599.94 M

Profile

Address
1 Prospect West
Chippenham Wiltshire SN14 6FH
United Kingdom
Employees -
Website http://vectura.com
Updated 07/08/2019
Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. It operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France.

Financials

View All
Created with Highcharts 5.0.14Vectura Group PLCNet Income. Fiscal year is January-December. All values GBP Thousands.5 9005 9002 3002 3003 7003 70042 79942 79985 70085 70088 20088 200201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Vectura Group PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.30 50030 50036 50036 50058 00058 000168 666168 666148 000148 000160 500160 500201320142015201620172018050k100k150k200k

Bruno Francois Jules Angelici
Non-Executive Chairman
James Ward-Lilley
Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.